State Street Corp Lucira Health, Inc. Transaction History

State Street Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.12 - $0.93 $3,660 - $28,371	-30,507 Closed	0 $0
Q2 2022 Aug 15, 2022	SELL	$1.44 - $3.94 $6,311 - $17,269	-4,383 Reduced 12.56%	30,507 $57,000
Q1 2022 May 16, 2022	SELL	$2.86 - $8.83 $41,784 - $129,006	-14,610 Reduced 29.52%	34,890 $125,000
Q3 2021 Nov 15, 2021	BUY	$6.05 - $10.81 $59,290 - $105,938	9,800 Added 24.69%	49,500 $376,000
Q2 2021 Aug 16, 2021	SELL	$4.56 - $11.45 $189,198 - $475,071	-41,491 Reduced 51.1%	39,700 $264,000
Q1 2021 May 17, 2021	BUY	$11.65 - $37.0 $945,875 - $3 Million	81,191 New	81,191 $982,000

Ticker LHDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,106,500
Market Cap $1.2M
Description
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a paten...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.